ATAI ATAI Life Sciences N.V.

Nasdaq atai.life


$ 6.09 $ 0.60 (11.11 %)    

Tuesday, 14-Oct-2025 19:19:36 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 6
$ 5.35
$ 5.86 x 35
$ 6.25 x 2,008
$ 5.34 - $ 6.24
$ 1.04 - $ 6.24
9,789,703
na
1.29B
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-17-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-24-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-30-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 atai-life-sciences-remains-undervalued-analyst-initiates-with-around-125-stock-upside

Atai Life Sciences' BPL-003 shows strong Phase 2b results for treatment-resistant depression, with potential $2.5 billion s...

Core News & Articles

https://www.marijuanamoment.net/psychedelics-show-promise-as-an-entirely-new-type-of-anti-inflammatory-treatment-research-sugge...

 needham-initiates-coverage-on-atai-life-sciences-with-buy-rating-announces-price-target-of-12

Needham analyst Ami Fadia initiates coverage on ATAI Life Sciences (NASDAQ:ATAI) with a Buy rating and announces Price Targe...

Core News & Articles

https://www.marijuanamoment.net/new-york-lawmakers-hold-hearing-psilocybins-medical-benefits-amid-broader-debate-over-psychedel...

 atai-life-sciences-nv-says-certain-selling-securityholders-may-offer-and-sell-common-shares-including-up-to-453m-shares-by-selling-securityholders

-SEC Filing

 atai-life-sciences-nv-files-for-potential-mixed-shelf-size-not-disclosed

-SEC Filing

 atai-life-sciences-experimental-depression-drug-shows-sustained-benefit-in-treatment-resistant-patients

Atai Life Sciences and Beckley Psytech report strong BPL-003 study results in treatment-resistant depression, with Phase 3 tria...

 hc-wainwright--co-reiterates-buy-on-atai-life-sciences-maintains-15-price-target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Buy and maintains $15...

 atai-life-sciences-and-beckley-psytech-announce-clinical-evidence-supporting-two-dose-induction-of-bpl-003-with-sustained-antidepressant-benefits

 Open-label study evaluated a two-dose induction regimen of BPL-003 (8 mg followed by 12 mg two weeks later) in patients with t...

 cathie-woods-ark-bets-big-on-solana-treasury-play-makes-162m-investment-in-brera-holdings-as-stock-explodes-225

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and b...

 atai-life-sciences-awarded-multi-year-milestone-driven-grant-worth-up-to-114m-by-national-institute-on-drug-abuse-part-of-national-institutes-of-health

atai Life Sciences (NASDAQ:ATAI) ("atai" or "Company"), a clinical-stage biopharmaceutical company on a mission...

Core News & Articles

https://www.marijuanamoment.net/massachusetts-lawmakers-approve-bill-to-create-psychedelic-therapy-pilot-program/

Core News & Articles

https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/

Core News & Articles

https://www.marijuanamoment.net/gop-senator-is-confident-psychedelics-access-will-expand-under-trump-saying-many-veterans-speak...

Core News & Articles

https://www.marijuanamoment.net/u-s-senate-committee-to-hold-hearing-on-benefits-of-psychedelics-for-military-veterans/

 atai-life-sciences-q2-eps-014-misses-012-estimate-sales-719000k-up-from-273000k-yoy

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of ...

 hc-wainwright--co-maintains-buy-on-atai-life-sciences-raises-price-target-to-15

HC Wainwright & Co. analyst Patrick Trucchio maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and raises the price ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION